Biallelic THOC6 pathogenic variants: Prenatal phenotype and review of the literature.


Journal

Birth defects research
ISSN: 2472-1727
Titre abrégé: Birth Defects Res
Pays: United States
ID NLM: 101701004

Informations de publication

Date de publication:
06 2022
Historique:
revised: 17 03 2022
received: 28 08 2021
accepted: 22 03 2022
pubmed: 16 4 2022
medline: 3 6 2022
entrez: 15 4 2022
Statut: ppublish

Résumé

The THOC6 protein is a component of the THO complex. It is involved in mRNA transcription, processing and nuclear export. Interestingly molecular biallelic loss-of-function variants of the THOC6 gene were identified in the Beaulieu-Boycott-Innes syndrome (BBIS- OMIM # 613680). This condition was described in 17 patients and is characterized by a moderate to severe intellectual disability, facial dysmorphic features and severe birth defects such as heart, skeletal, ano-genital and renal congenital malformations. In the present study, we report on a new family with two affected sibs. The 6-year-old female had severe intellectual disability with autistic features, feeding difficulties, growth delay, facial dysmorphic, and congenital malformations (hand, skeletal and cardiac anomalies). The male fetus presented antenatally with a cystic hygroma associated with severe aortic and left ventricular hypoplasia. Autopsy, after termination of pregnancy at 15 weeks of gestation, showed facial dysmorphic, short right thumb and hypospadias. Exome sequencing detected in both sibs compound heterozygous variants of the THOC6 gene (NM_024339.3, GRCh37): the already reported c.[298T>A;700G>T;824G>A] haplotype and a novel variant c.977T>G, p.(Val326Gly). We made a review of the literature of 17 BBIS reported patients including our two siblings. Severe to moderate ID and congenital malformations were constant. Prenatal and postnatal failure to thrive were frequent. Brain MRI were not specific. Prenatal findings were reported in 40% of cases but we described the first case of cystic hygroma. The present study reports extends the prenatal delineation of the phenotypic features observed in association with the presence of THOC6 variants. In addition, it underscores the intrafamilial phenotypic variability observed in BBIS.

Sections du résumé

BACKGROUND
The THOC6 protein is a component of the THO complex. It is involved in mRNA transcription, processing and nuclear export. Interestingly molecular biallelic loss-of-function variants of the THOC6 gene were identified in the Beaulieu-Boycott-Innes syndrome (BBIS- OMIM # 613680). This condition was described in 17 patients and is characterized by a moderate to severe intellectual disability, facial dysmorphic features and severe birth defects such as heart, skeletal, ano-genital and renal congenital malformations.
METHODS
In the present study, we report on a new family with two affected sibs. The 6-year-old female had severe intellectual disability with autistic features, feeding difficulties, growth delay, facial dysmorphic, and congenital malformations (hand, skeletal and cardiac anomalies). The male fetus presented antenatally with a cystic hygroma associated with severe aortic and left ventricular hypoplasia. Autopsy, after termination of pregnancy at 15 weeks of gestation, showed facial dysmorphic, short right thumb and hypospadias.
RESULTS
Exome sequencing detected in both sibs compound heterozygous variants of the THOC6 gene (NM_024339.3, GRCh37): the already reported c.[298T>A;700G>T;824G>A] haplotype and a novel variant c.977T>G, p.(Val326Gly).
DISCUSSION
We made a review of the literature of 17 BBIS reported patients including our two siblings. Severe to moderate ID and congenital malformations were constant. Prenatal and postnatal failure to thrive were frequent. Brain MRI were not specific. Prenatal findings were reported in 40% of cases but we described the first case of cystic hygroma. The present study reports extends the prenatal delineation of the phenotypic features observed in association with the presence of THOC6 variants. In addition, it underscores the intrafamilial phenotypic variability observed in BBIS.

Identifiants

pubmed: 35426486
doi: 10.1002/bdr2.2011
doi:

Substances chimiques

RNA-Binding Proteins 0
THOC6 protein, human 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

499-504

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Accogli, A., Scala, M., Calcagno, A., Castello, R., Torella, A., Musacchia, F., … Capra, V. (2018). Novel CNS malformations and skeletal anomalies in a patient with Beaulieu-Boycott-Innes syndrome. American Journal of Medical Genetics. Part A, 176(12), 2835-2840. https://doi.org/10.1002/ajmg.a.40534
Amos, J. S., Huang, L., Thevenon, J., Kariminedjad, A., Beaulieu, C. L., Masurel-Paulet, A., … Care4Rare Canada Consortium. (2017). Autosomal recessive mutations in THOC6 cause intellectual disability: Syndrome delineation requiring forward and reverse phenotyping. Clinical Genetics, 91(1), 92-99. https://doi.org/10.1111/cge.12793
Anazi, S., Alshammari, M., Moneis, D., Abouelhoda, M., Ibrahim, N., & Alkuraya, F. S. (2016). Confirming the candidacy of THOC6 in the etiology of intellectual disability. American Journal of Medical Genetics. Part A, 170A(5), 1367-1369. https://doi.org/10.1002/ajmg.a.37549
Beaulieu, C. L., Huang, L., Innes, A. M., Akimenko, M.-A., Puffenberger, E. G., Schwartz, C., … Boycott, K. M. (2013). Intellectual disability associated with a homozygous missense mutation in THOC6. Orphanet Journal of Rare Diseases, 8, 62. https://doi.org/10.1186/1750-1172-8-62
Boycott, K. M., Beaulieu, C., Puffenberger, E. G., McLeod, D. R., Parboosingh, J. S., & Innes, A. M. (2010). A novel autosomal recessive malformation syndrome associated with developmental delay and distinctive facies maps to 16ptel in the Hutterite population. American Journal of Medical Genetics. Part A, 152A(6), 1349-1356. https://doi.org/10.1002/ajmg.a.33379
Casey, J., Jenkinson, A., Magee, A., Ennis, S., Monavari, A., Green, A., … Hughes, J. (2016). Beaulieu-Boycott-Innes syndrome: An intellectual disability syndrome with characteristic facies. Clinical Dysmorphology, 25(4), 146-151. https://doi.org/10.1097/MCD.0000000000000134
Gupta, N., Yadav, S., Gurramkonda, V. B., Vl, R., Sg, T., & Kabra, M. (2020). First report of THOC6 related intellectual disability (Beaulieu Boycott Innes syndrome) in two siblings from India. European Journal of Medical Genetics, 63(3), 103742. https://doi.org/10.1016/j.ejmg.2019.103742
Mattioli, F., Isidor, B., Abdul-Rahman, O., Gunter, A., Huang, L., Kumar, R., … Piton, A. (2019). Clinical and functional characterization of recurrent missense variants implicated in THOC6-related intellectual disability. Human Molecular Genetics, 28(6), 952-960. https://doi.org/10.1093/hmg/ddy391
Zhang, Q., Chen, S., Qin, Z., Zheng, H., & Fan, X. (2020). The first reported case of Beaulieu-Boycott-Innes syndrome caused by two novel mutations in THOC6 gene in a Chinese infant. Medicine, 99(15), e19751. https://doi.org/10.1097/MD.0000000000019751

Auteurs

Lyse Ruaud (L)

INSERM UMR 1141, Neurodiderot, Université de Paris, Paris, France.
Département de Génétique, APHp.Nord, Hopital Universitaire Robert-Debré, Paris, France.

Nathalie Roux (N)

APHp.Centre, Hopital Necker-Enfants Malades, Service de Médecine Génomique des Maladies Rares, Paris, France.
Université de Paris, Paris, France.

Lucile Boutaud (L)

APHp.Centre, Hopital Necker-Enfants Malades, Service de Médecine Génomique des Maladies Rares, Paris, France.
Institut Imagine, INSERM U1163, Paris, France.

Bettina Bessières (B)

APHp.Centre, Hopital Necker-Enfants Malades, Service de Médecine Génomique des Maladies Rares, Paris, France.

Faustine Ageorges (F)

Département de Génétique, APHp.Nord, Hopital Universitaire Robert-Debré, Paris, France.

Amale Achaiaa (A)

APHp.Centre, Hopital Necker-Enfants Malades, Service de Médecine Génomique des Maladies Rares, Paris, France.

Christine Bole (C)

Institut Imagine, Plateforme de Génomique, Paris, France.

Patrick Nitschke (P)

Université de Paris, Paris, France.
Institut Imagine, Plateforme de Génomique, Paris, France.

Cécile Masson (C)

Institut Imagine, Plateforme de Génomique, Paris, France.

Michel Vekemans (M)

APHp.Centre, Hopital Necker-Enfants Malades, Service de Médecine Génomique des Maladies Rares, Paris, France.
Université de Paris, Paris, France.
Institut Imagine, INSERM U1163, Paris, France.

Alain Verloes (A)

INSERM UMR 1141, Neurodiderot, Université de Paris, Paris, France.
Département de Génétique, APHp.Nord, Hopital Universitaire Robert-Debré, Paris, France.

Tania Attie-Bitach (T)

APHp.Centre, Hopital Necker-Enfants Malades, Service de Médecine Génomique des Maladies Rares, Paris, France.
Université de Paris, Paris, France.
Institut Imagine, INSERM U1163, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH